Clear Cell Renal Cell Carcinoma Clinical Trials

ReadTheTrial indexes 3 studies for Clear Cell Renal Cell Carcinoma. The most common development stage is Phase 2 (1 trials). Each trial page translates ClinicalTrials.gov eligibility, outcomes, and design into patient-friendly language so you can compare options quickly.

3 clinical trials found for Clear Cell Renal Cell Carcinoma.

Pipeline by Phase

PhaseTrialsDistribution
Phase 2 1
33%
Phase 1 1
33%
Phase 3 1
33%

Trial Status Breakdown

Trials for Clear Cell Renal Cell Carcinoma

Pilot Phase II Trial Evaluating Safety and Feasibility of Neoadjuvant Botensilimab and Balstilimab in Clear Cell Renal Cell Carcinoma (NEO RoBOT)

NCT07516366 · NOT YET RECRUITING · Phase 2

Combination Nivolumab and Ipilimumab With and Without Camu Camu in First Line Treatment of Metastatic Renal Cell Carcinoma

NCT06049576 · SUSPENDED · Phase 1

PD-Inhibitor (Nivolumab) and Ipilimumab Followed by Nivolumab Vs. VEGF TKI Cabozantinib With Nivolumab: A Phase III Trial in Metastatic Untreated REnal Cell CancEr [PDIGREE]

NCT03793166 · ACTIVE NOT RECRUITING · Phase 3

Frequently Asked Questions

What clinical trials are available for Clear Cell Renal Cell Carcinoma?

There are 3 clinical trials listed for Clear Cell Renal Cell Carcinoma. These span various phases from early safety studies to post-approval monitoring. Browse the trial listings below for details.

How do I find recruiting Clear Cell Renal Cell Carcinoma trials?

Look for trials with "Recruiting" status in the listings below, or visit our recruiting page to filter by condition. Each trial page includes decoded eligibility criteria to help you determine if you qualify.

What phases are Clear Cell Renal Cell Carcinoma trials in?

Current Clear Cell Renal Cell Carcinoma trials are distributed across: Phase 2 (1), Phase 1 (1), Phase 3 (1).

Find More Trials